Department of Optometry and Visual Sciences, School of Health and Psychological Sciences, City, University of London, London, UK.
Ophthalmic Physiol Opt. 2024 Jan;44(1):96-114. doi: 10.1111/opo.13245. Epub 2023 Nov 20.
Nonadherence to medication reduces treatment effectiveness, and in chronic conditions it can significantly reduce health outcomes. In glaucoma, suboptimal adherence can lead to sight loss, which places a greater financial burden on society and reduces patients' quality of life. Interventions to improve adherence have so far had limited success and lack robust theoretical underpinnings. A better understanding of the determinants of medication adherence behaviour is needed in order to develop interventions that can target these factors more effectively. This systematic review aims to identify modifiable barriers and enablers to glaucoma medication adherence and identify factors most likely to influence adherence behaviour.
We searched CINAHL, MEDLINE, PsycINFO, EMBASE, the Cochrane Library and sources of grey literature up to August 2022 for studies reporting determinants of glaucoma medication adherence. Data describing modifiable barriers/enablers to adherence were extracted and analysed using the Theoretical Domains Framework (TDF), a behavioural framework consisting of 14 domains representing theoretical factors that most likely influence behaviour. Data were deductively coded into one of the TDF domains and inductively analysed to generate themes. Key behavioural domains influencing medication adherence were identified by frequency of study coding, level of elaboration and expressed importance. Eighty-three studies were included in the final synthesis. Four key domains influencing glaucoma medication adherence were identified: 'Environmental Context and Resources', 'Knowledge', 'Skills' and 'Memory, Attention and decision processes'. Frequently reported barriers included complex eyedrop regimens, lack of patient understanding of their condition, forgetfulness and difficulties administering eyedrops. Whereas simplified treatments, knowledgeable educated patients and good patient-practitioner relationships were enablers to adherence.
We identified multiple barriers and enablers affecting glaucoma medication adherence. Four theoretical domains were found to be key in influencing adherence behaviour. These findings can be used to underpin the development of behaviour change interventions that aim to improve medication adherence.
药物不依从会降低治疗效果,在慢性病中,它会显著降低健康结果。在青光眼患者中,不依从药物治疗可能导致失明,这会给社会带来更大的经济负担,并降低患者的生活质量。迄今为止,改善依从性的干预措施收效甚微,缺乏坚实的理论基础。为了开发能够更有效地针对这些因素的干预措施,我们需要更好地了解影响药物依从性行为的决定因素。本系统评价旨在确定影响青光眼药物依从性的可改变障碍和促进因素,并确定最有可能影响依从性行为的因素。
我们检索了 CINAHL、MEDLINE、PsycINFO、EMBASE、Cochrane 图书馆和灰色文献来源,以获取截至 2022 年 8 月报告青光眼药物依从性决定因素的研究。提取并使用理论领域框架(TDF)分析描述依从性可改变障碍/促进因素的数据,该框架由 14 个代表最有可能影响行为的理论因素的领域组成。数据被演绎地编码到 TDF 中的一个领域,并进行归纳分析以生成主题。通过研究编码频率、阐述程度和表达重要性,确定影响药物依从性的关键行为领域。最终综合分析纳入了 83 项研究。确定了影响青光眼药物依从性的四个关键领域:“环境背景和资源”、“知识”、“技能”和“记忆、注意力和决策过程”。经常报道的障碍包括滴眼剂方案复杂、患者对病情缺乏了解、健忘和滴眼剂使用困难。而简化治疗、知识渊博的患者和良好的医患关系是依从性的促进因素。
我们确定了影响青光眼药物依从性的多个障碍和促进因素。发现四个理论领域是影响依从性行为的关键。这些发现可以为改善药物依从性的行为改变干预措施的开发提供依据。